Bio Essence (BIOE) Gross Margin (2020 - 2026)
Bio Essence (BIOE) recorded quarterly Gross Margin of 63.8% in Q1 2026, down 17.45% quarter-over-quarter from 77.29% in Q4 2025, and down 2898.0% on a YoY basis from 2.28% in Q1 2025.
Bio Essence (BIOE) Gross Margin (2020 - 2026) Analysis & Trends
Bio Essence's Gross Margin history runs 7 years deep, the most recent figure standing at 63.8% for Q1 2026.
- In Q1 2026, Gross Margin fell 2898.0% year-over-year to 63.8%; the TTM figure through Mar 2026 stood at 72.7% (up 403.0% YoY), while the FY2025 annual figure was 75.28%, up 826.0% from the prior year.
- Gross Margin was 63.8% for Q1 2026 at Bio Essence, down from 77.29% in the prior quarter.
- In the past five years, Gross Margin ranged from a high of 92.78% in Q1 2025 to a low of 8.49% in Q4 2022.
- Historically, Gross Margin has averaged 50.25% across 5 years, with a median of 54.61% in 2022.
- The sharpest annual moves came in 2022 and 2024: Gross Margin sank 3747 bps in 2022, then soared 6098 bps in 2024.
- A 5-year view of Gross Margin shows it stood at 8.49% in 2022, then jumped by 235 bps to 11.47% in 2023, then soared by 532 bps to 72.45% in 2024, then climbed by 7 bps to 77.29% in 2025, then decreased by 17 bps to 63.8% in 2026.
- The last three Gross Margin figures came in at 63.8% (Q1 2026), 77.29% (Q4 2025), and 70.0% (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | 49.52% |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | 71.66% |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | 82.93% |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | 49.50% |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | 98.31% |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | 57.26% |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | -293.83% |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | 65.25% |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | 61.20% |
| 10 | Bio Essence | - | - | 319,353.00 | 63.80% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 63.80% |
| Dec 31, 2025 | 77.29% |
| Sep 30, 2025 | 70.00% |
| Jun 30, 2025 | 65.08% |
| Mar 31, 2025 | 92.78% |
| Dec 31, 2024 | 72.45% |
| Sep 30, 2024 | 60.13% |
| Jun 30, 2024 | 70.00% |
| Mar 31, 2024 | 50.22% |
| Dec 31, 2023 | 11.47% |
| Sep 30, 2023 | 15.91% |
| Jun 30, 2023 | 41.67% |
| Mar 31, 2023 | 49.23% |
| Dec 31, 2022 | -8.49% |
| Sep 30, 2022 | 45.04% |
| Jun 30, 2022 | 54.61% |
| Mar 31, 2022 | 22.99% |
| Dec 31, 2021 | 28.97% |
| Sep 30, 2021 | 42.02% |
| Jun 30, 2021 | 27.34% |